Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9baf3defa9dc998356da178a79d4920 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8afd09a95e6a84ec29366a8252e98a5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cedac6520613e2ad7bc39c08cd58c86b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2006-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb083f78d2fcaea63e73b2529095a0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796ee6f3047d71c04c1b51d326c75b46 |
publicationDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007043054-A1 |
titleOfInvention |
Treatment and monitoring disease state of liver cancer |
abstract |
The present invention provide a method for determining and monitoring disease state in a patient having liver cancer, e.g. for determining the severity of the disease, for determining the effectiveness of an anti-cancer therapeutic treatment of a patient and for selecting patients to likely to benefit from an anti-cancer therapeutic treatment involving the use of A3AR agonists for example IB-MECA. The method of the invention is based on the determination of level of expression of A3 adenosine receptor agonist in white blood cells, the level being indicative of the disease state. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9181253-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8735407-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013111132-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916570-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796291-B2 |
priorityDate |
2005-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |